Pages

Friday, February 12, 2016

Cure Talk Tuesday Feb 16

Everything you need to know about Daratumumab and Multiple Myeloma

FDA recently approved daratumumab (Darzalex) to treat patients with multiple myeloma who have received at least three prior treatments. Daratumumab is the first monoclonal antibody approved for treating myeloma and provides another treatment option for patients who have become resistant to other therapies. Our myeloma panel is talking to the father of daratumumab, Dr. Torben Plesner, on the use of this drug in treating multiple myeloma.




Register at: http://www.curetalks.com/event/rsvp/Everything-you-need-to-know-about-Daratumumab-and-Multiple-Myeloma/248/?upcoming=yes

2 comments:

  1. All things considered, nothing I can say except for incredible! I trust you'll make more helpful articles in the up and coming days.
    Tenmou, the Angel Investment Group in Bahrain Case Solution

    ReplyDelete
  2. Pleasant line use and great picture this post. this post will be successfully a debt of gratitude is in order for sharing.
    Online Programming Homework Help

    ReplyDelete

Berenson Oncology Success Rate

 Some reading about my myeloma specialist's success rate. A press release and an article from Targeted Oncology.